Monday, 10 August 2020


US Joins India in trials for ayurveda formulations against COVID-19

15 July 2020 | News

Research begins evidencing Ayurvedic Medicine as COVID-19 Treatment

Photo Credit: Freepik

Photo Credit: Freepik

A group of eminent Indian-American scientists and doctors met with the Indian Ambassador to the US, Taranjit Singh Sandhu, to discuss joint Indian and US trials of Ayurveda formulations for COVID-19.

Researchers argue that these medicines have a remarkable record in treating various diseases including COVID-19. They believe that clinical trials are needed to “get rid of all the doubts” around its effectiveness. A huge network of institutional engagements have finally brought scientific communities between the two countries together in the fight against the novel coronavirus.

"Researchers from IIT-Delhi are cited for the idea that Ashwagandha, an Ayurvedic medicine, can treat COVID-19. The plant contains withanone which can impact the COVID-19’s enzyme responsible for replication, if used along with an active ingredient of propolis called Caffeic Acid Phenethyl Ester (CAPE).” says Indian Ambassador to the US, Tahitranjit Singh Sandhu.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls